davunetide and Parkinsonian-Disorders

davunetide has been researched along with Parkinsonian-Disorders* in 1 studies

Other Studies

1 other study(ies) available for davunetide and Parkinsonian-Disorders

Article	Year
Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis. Journal of molecular neuroscience : MN, 2020, Volume: 70, Issue:7 Topics: Amino Acid Motifs; Amyotrophic Lateral Sclerosis; Animals; Axonal Transport; Cell Line, Tumor; Disease Models, Animal; Dynamins; Endocytosis; Homeodomain Proteins; Hydrazones; Mice; Mice, Knockout; Microtubule-Associated Proteins; Microtubules; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Oligopeptides; Parkinsonian Disorders; Tauopathies	2020

Article

Year

Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis.

Journal of molecular neuroscience : MN, 2020, Volume: 70, Issue:7

Topics: Amino Acid Motifs; Amyotrophic Lateral Sclerosis; Animals; Axonal Transport; Cell Line, Tumor; Disease Models, Animal; Dynamins; Endocytosis; Homeodomain Proteins; Hydrazones; Mice; Mice, Knockout; Microtubule-Associated Proteins; Microtubules; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Oligopeptides; Parkinsonian Disorders; Tauopathies

2020